131 related articles for article (PubMed ID: 35917927)
1. Hypomethylated gene RAC3 induces cell proliferation and invasion by increasing FASN expression in endometrial cancer.
Meijuan C; Fang L; Min F; Qian W
Int J Biochem Cell Biol; 2022 Sep; 150():106274. PubMed ID: 35917927
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis identifies RAC3 as an immune-related prognostic biomarker associated with chemotherapy sensitivity in endometrial cancer.
Huang P; Qian Y; Xia Y; Wang S; Xu C; Zhu X; Gao Q
J Cell Mol Med; 2023 Aug; 27(16):2385-2397. PubMed ID: 37386813
[TBL] [Abstract][Full Text] [Related]
3. Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
Chen M; Nie Z; Cao H; Gao Y; Wen X; Zhang C; Zhang S
Pathol Oncol Res; 2021; 27():598460. PubMed ID: 34257551
[No Abstract] [Full Text] [Related]
4. Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression.
He Y; Xu S; Qi Y; Tian J; Xu F
J Ovarian Res; 2021 Nov; 14(1):163. PubMed ID: 34789312
[TBL] [Abstract][Full Text] [Related]
5. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
[TBL] [Abstract][Full Text] [Related]
6. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
Yang Q; Yu B; Sun J
Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
[TBL] [Abstract][Full Text] [Related]
7. RAC3 is a pro-migratory co-activator of ERα.
Walker MP; Zhang M; Le TP; Wu P; Lainé M; Greene GL
Oncogene; 2011 Apr; 30(17):1984-94. PubMed ID: 21217774
[TBL] [Abstract][Full Text] [Related]
8. Synaptotagmin-like protein 1 is a potential diagnostic and prognostic biomarker in endometrial cancer based on bioinformatics and experiments.
Meijuan C; Meng X; Fang L; Qian W
J Ovarian Res; 2023 Jan; 16(1):16. PubMed ID: 36653850
[TBL] [Abstract][Full Text] [Related]
9. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
[TBL] [Abstract][Full Text] [Related]
10. Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer.
Zheng W; Zhang J; Song Q; Xu Y; Zhu M; Ma J
DNA Cell Biol; 2021 Mar; 40(3):469-481. PubMed ID: 33600260
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer.
Zhang P; Su T; Zhang S
J Immunol Res; 2021; 2021():5574176. PubMed ID: 34189143
[TBL] [Abstract][Full Text] [Related]
12. Increased FOXM1 Expression was Associated with the Prognosis and the Recruitment of Neutrophils in Endometrial Cancer.
Chen J; Yang P; Li S; Feng Y
J Immunol Res; 2023; 2023():5437526. PubMed ID: 37159818
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.
Li F; Zhang Y; Shi Y; Liu S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
[TBL] [Abstract][Full Text] [Related]
14. NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics.
Qiu X; Gao Z; Shao J; Li H
Ann Hum Genet; 2020 Nov; 84(6):437-446. PubMed ID: 32628282
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer.
Rahman MT; Nakayama K; Ishikawa M; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Iida K; Miyazaki K
Oncology; 2013; 84(3):166-73. PubMed ID: 23306391
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patients.
Du H; Zhang L; Chen J; Chen X; Qiang R; Ding X; Wang Y; Yang X
Cancer Cell Int; 2024 Jan; 24(1):20. PubMed ID: 38195567
[TBL] [Abstract][Full Text] [Related]
17. Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines.
Gest C; Joimel U; Huang L; Pritchard LL; Petit A; Dulong C; Buquet C; Hu CQ; Mirshahi P; Laurent M; Fauvel-Lafève F; Cazin L; Vannier JP; Lu H; Soria J; Li H; Varin R; Soria C
BMC Cancer; 2013 Feb; 13():63. PubMed ID: 23388133
[TBL] [Abstract][Full Text] [Related]
18. Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma.
Lan H; Yuan J; Chen X; Liu C; Guo X; Wang X; Song J; Cao K; Xiao S
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34859821
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value and Immune-Infiltration Pattern of
Yang Z; Shen X; Luo S; Li Y
Dis Markers; 2022; 2022():9621701. PubMed ID: 35126794
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer.
Chen P; Yang Y; Zhang Y; Jiang S; Li X; Wan J
Aging (Albany NY); 2020 Feb; 12(4):3371-3387. PubMed ID: 32074080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
